Stefania Fasano

Cardiff, WLS, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Correction: Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors.

Correction: Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors.

Journal: eLife

Published: February 07, 2025

Editorial: Animal-friendly methods for rodent behavioral testing in neuroscience research.

Editorial: Animal-friendly methods for rodent behavioral testing in neuroscience research.

Journal: Frontiers in behavioral neuroscience

Published: May 11, 2024

Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2.

Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2.

Journal: EMBO molecular medicine

Published: March 10, 2022

Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia.

Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia.

Journal: British journal of pharmacology

Published: February 24, 2021

Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin.

Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin.

Journal: Scientific reports

Published: June 04, 2018

The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice.

The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: May 03, 2018

Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists.

Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists.

Journal: British journal of pharmacology

Published: April 13, 2017

Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors.

Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors.

Journal: eLife

Published: April 20, 2016

Severe Intellectual Disability and Enhanced Gamma-Aminobutyric Acidergic Synaptogenesis in a Novel Model of Rare RASopathies.

Severe Intellectual Disability and Enhanced Gamma-Aminobutyric Acidergic Synaptogenesis in a Novel Model of Rare RASopathies.

Journal: Biological psychiatry

Published: April 01, 2016

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

Journal: Progress in neurobiology

Published: March 11, 2015

Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesia.

Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesia.

Journal: Annals of clinical and translational neurology

Published: September 16, 2014

Behavioral methods for the study of the Ras-ERK pathway in memory formation and consolidation: passive avoidance and novel object recognition tests.

Behavioral methods for the study of the Ras-ERK pathway in memory formation and consolidation: passive avoidance and novel object recognition tests.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: January 29, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026